Halozyme Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $101.8M
Liabilities Breakdown FY2013
Total Liabilities: $121.8M
Asset Breakdown
Total Assets: $101.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.4M | 26.9% |
| Accounts Receivable | $9.1M | 8.9% |
| Inventory | $6.2M | 6.1% |
| Property, Plant & Equipment | $3.4M | 3.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $55.7M | 54.8% |
Liabilities Breakdown
Total Liabilities: $121.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 2.6% |
| Long-Term Debt | $49.8M | 40.9% |
| Other Liabilities | $68.9M | 56.6% |